title: Histamine release during rapid vancomycin administration.
authors.affiliation: Department of Anaesthesia and Critical Care, University of Chicago, IL 60637, USA.
authors.forename: C
authors.initials: C
authors.lastname: Renz
authors.forename: J
authors.initials: J
authors.lastname: Lynch
authors.forename: J
authors.initials: J
authors.lastname: Thurn
authors.forename: J
authors.initials: J
authors.lastname: Moss
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D002927:Cimetidine / Q000008:administration & dosage / Q000627:therapeutic use; D004155:Diphenhydramine / Q000008:administration & dosage / Q000627:therapeutic use; D004311:Double-Blind Method; D004342:Drug Hypersensitivity / Q000209:etiology / Q000517:prevention & control*; D005076:Exanthema / Q000139:chemically induced / Q000517:prevention & control; D006632:Histamine / Q000097:blood; D006634:Histamine H1 Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D006635:Histamine H2 Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D006636:Histamine Release / Q000187:drug effects*; D006801:Humans; D007022:Hypotension / Q000139:chemically induced / Q000517:prevention & control; D007262:Infusions, Intravenous; D011446:Prospective Studies; D011537:Pruritus / Q000139:chemically induced / Q000517:prevention & control; D013997:Time Factors; D014640:Vancomycin / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D006634:Histamine H1 Antagonists; D006635:Histamine H2 Antagonists; D014640:Vancomycin; D002927:Cimetidine; D006632:Histamine; D004155:Diphenhydramine